Neoantigen-targeted TIL Analysis Services

Online Inquiry

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

At Creative Biolabs, we are dedicated to advancing cancer immunotherapy through innovative techniques and personalized approaches. Our Neoantigen-Targeted Tumor-Infiltrating Lymphocyte (TIL) Analysis Services are designed to support researchers and clinicians in identifying and leveraging neoantigens for effective cancer treatments. With a focus on Neoantigen Screening and Discovery as well as Tumor Mutation Burden (TMB) Analysis, our services aim to enhance the precision and efficacy of immunotherapies.

Understanding Neoantigens and TILs

Neoantigens arise from tumor-specific mutations and are absent in normal tissues, making them attractive targets for immunotherapy. An immune cell type known as TILs can go into tumors and may be able to identify and eliminate cancer cells that exhibit neoantigens. By focusing on these two elements, Creative Biolabs launched the neoantigen-targeted TIL analysis service to provide a new way to improve the efficacy of cancer treatment strategies.

Fig.1 Historical overview. Fig.1 Historical overview of tumor-specific neoantigens.¹

Our Featured Services

These are our latest Neoantigen-targeted TIL Analysis featured services! But our capabilities don't stop there, if you have more needs in this field, don't hesitate to contact our technicians for assistance.

Neoantigen Screening and Discovery Service

Creative Biolabs offers comprehensive Neoantigen Screening and Discovery Services that include the identification of tumor-specific mutations through advanced genomic sequencing, bioinformatics analysis to predict immunogenic peptides, and laboratory validation of neoantigens for personalized cancer immunotherapy.

Please click on the keywords above to learn more information!

Tumor Mutation Burden (TMB) Analysis Services

Creative Biolabs provides Tumor Mutation Burden Analysis Services that involve comprehensive genomic sequencing to accurately quantify the total number of mutations present in a tumor, thereby assessing its potential for generating neoantigens and predicting responses to immunotherapy.

Please click on the keywords above to learn more information!

Importance of Neoantigen-targeted TIL Analysis

Neoantigen-targeted TIL analysis is crucial for the advancement of personalized cancer immunotherapies. Tumor-specific antigens known as neoantigens are produced by genetic alterations particular to cancer, which makes them perfect targets for immune detection. By analyzing these neoantigens, we can identify the most relevant targets for TILs, ensuring the therapy is tailored to a specific tumor profile. This process not only enhances the efficacy of TIL-based therapies by selecting and expanding TILs that specifically target the tumor but also helps overcome tumor immune evasion strategies. Furthermore, neoantigen analysis allows for the monitoring of immune responses during treatment, guiding adjustments to improve outcomes. Overall, neoantigen-targeted TIL analysis enables more precise, effective, and safe cancer therapies, paving the way for personalized, cutting-edge treatments.

Why Choose Creative Biolabs

By choosing Creative Biolabs for your Neoantigen-targeted TIL Analysis Services, you gain access to a full suite of advanced tools and technologies designed to enhance the development of personalized TIL therapies. Our services help you navigate the complexities of tumor genomics and immunology, providing precise insights that can improve the efficacy of your therapies.

By partnering with us, you benefit from:

Comprehensive neoantigen discovery using the latest sequencing technologies and bioinformatics tools.

Accurate TMB analysis to assess tumor mutation load and predict response to immunotherapy.

Customized solutions tailored to your specific tumor type and immunotherapy goals.

High-throughput, reliable assays to validate and prioritize neoantigen targets.

Expert consultation and support to guide your TIL therapy development with data-driven insights.

Our integrated approach to neoantigen screening and TMB analysis allows you to make informed decisions in selecting the most promising therapeutic targets, enhancing the development of personalized, effective TIL-based immunotherapies. With our services, you can confidently move forward in developing cutting-edge treatments that harness the power of the immune system to fight cancer.

Contact Us for More

For more information or to discuss how our Neoantigen-targeted TIL Analysis Services can support your TIL therapy program, please contact us today.

Reference

Xie, Na et al. "Neoantigens: promising targets for cancer therapy." Signal transduction and targeted therapy vol. 8,1 9. 6 Jan. Distributed under Open Access license CC BY 4.0, without modification.